Mary Lynne Hedley's Net Worth

$7.83 Million

Estimate Recalculated Nov 11, 2024 07:52AM EST

Who is Mary Lynne Hedley

Mary Lynne Hedley has an estimated net worth of $7.83 Million. This is based on reported shares across multiple companies, which include VEEVA SYSTEMS INC, Abraxis BioScience, Inc., Receptos, Inc., Centessa Pharmaceuticals plc, bluebird bio, Inc., Millendo Therapeutics, Inc., TESARO, Inc., ELI LILLY & Co, and MGI PHARMA INC.

SEC CIK

Mary Lynne Hedley's CIK is 0001340823

Past Insider Trading and Trends

2023 was Mary Lynne Hedley's most active year for acquiring shares with 19 total transactions. Mary Lynne Hedley's most active month to acquire stocks was the month of May. 2019 was Mary Lynne Hedley's most active year for disposing of shares, totalling 13 transactions. Mary Lynne Hedley's most active month to dispose stocks was the month of December. 2006 saw Mary Lynne Hedley paying a total of $1,134,750.00 for 95,000 shares, this is the most they've acquired in one year. In 2015 Mary Lynne Hedley cashed out on 27,590 shares for a total of $3,936,614.40, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

VEEVA SYSTEMS INC

Investor
Updated Sep 03, 2024
Form 4
Sep 03, 2024
6.10K
Options
Sep 01
Form 4
1.37K
Jun 20, 2024
6.10K
Grant
Jun 19
Form 4
Jun 03, 2024
4.73K
Options
Jun 01
Form 4
Mar 05, 2024
4.73K
Options
Mar 01
Form 4
-1.97%
-83.00
$191.02
-$15.85K
Dec 28, 2023
4.13K
Sale
ScheduledDec 27 - Dec 28
Form 4
Dec 01, 2023
4.82K
Options
Dec 01
Form 4
Sep 05, 2023
4.82K
Options
Sep 01
Form 4
-6.00%
-230.00
$207.87
-$47.81K
Jul 13, 2023
3.61K
Sale
Jul 12 - Jul 13
Form 4
1.21K
Jun 23, 2023
5.05K
Grant
Jun 21
Form 4
Jun 05, 2023
3.84K
Options
Jun 01
Form 4
Mar 03, 2023
3.84K
Options
Mar 01
Form 4
Dec 05, 2022
3.84K
Options
Dec 01
Form 4
Sep 06, 2022
3.84K
Options
Sep 01
Form 4
1.31K
Jun 13, 2022
3.84K
Grant
Jun 09
Form 4
Jun 02, 2022
2.53K
Options
Jun 01
Form 4
Mar 03, 2022
2.53K
Options
Mar 01
Form 4
Dec 03, 2021
2.53K
Options
Dec 01
Form 4
Sep 03, 2021
2.53K
Options
Sep 01
Form 4
-5.12%
-94.00
$314.81
-$29.59K
Jul 19, 2021
1.74K
Sale
ScheduledJul 15
Form 4
Jun 25, 2021
1.84K
Options
Jun 25
Form 4
788.00
Jun 24, 2021
2.40K
Grant
Jun 23
Form 4
-5.56%
-95.00
$270.66
-$25.71K
Apr 16, 2021
1.61K
Sale
ScheduledApr 14
Form 4
Mar 26, 2021
1.93K
Options
Mar 25
Form 4
-6.01%
-95.00
$288.54
-$27.41K
Jan 13, 2021
1.49K
Sale
ScheduledJan 11
Form 4
Dec 28, 2020
2.03K
Options
Dec 25
Form 4
Sep 28, 2020
2.03K
Options
Sep 25
Form 4
45.00
Jul 24, 2020
1.18K
Grant
Jul 23
Form 4
845.00
Jun 26, 2020
1.98K
Grant
Jun 25
Form 4
Jun 18, 2020
1.14K
Options
Jun 16
Form 4
May 19, 2020
1.14K
Options
May 16
Form 4
Feb 19, 2020
1.14K
Options
Feb 16
Form 4
Dec 16, 2019
1.14K
Options
Nov 16
Form 4
1.14K
Sep 19, 2019
1.14K
Grant
Sep 18
Form 3
Aug 19, 2019
Showing 34 results

Abraxis BioScience, Inc.

Executive VP Ops & CSO
Updated Jul 15, 2009
Form 4
75.00K
Jul 15, 2009
75.00K
Grant
Jul 13
Form 3
Jul 15, 2009
Showing 2 results

Receptos, Inc.

Investor
Updated Aug 27, 2015
Form 4
-100.00%
-27.59K
$199.42
-$3.94M
Aug 27, 2015
Disposition
Aug 27
Form 4
7.40K
Jun 01, 2015
7.40K
Grant
May 28
Form 4
1.39K
Jun 05, 2014
1.39K
Grant
Jun 03
Form 4
18.80K
Apr 14, 2014
18.80K
Grant
Apr 11
Form 3
Apr 14, 2014
Showing 5 results

Centessa Pharmaceuticals plc

Investor
Updated Jun 27, 2024
Form 4
48.00K
Jun 27, 2024
48.00K
Grant
Jun 25
Form 4
48.00K
Jun 23, 2023
48.00K
Grant
Jun 22
Form 4
48.00K
Jul 05, 2022
48.00K
Grant
Jun 30
Form 3
May 27, 2021
Showing 4 results

bluebird bio, Inc.

Investor
Updated Jun 22, 2018
Form 4
185.19%
5.00K
Jun 22, 2018
7.70K
Grant
Jun 20
Form 4
13.40K
Sep 20, 2017
13.40K
Grant
Sep 18
Form 3
Sep 20, 2017
Showing 3 results

Millendo Therapeutics, Inc.

Investor
Updated Jun 23, 2020
Form 4
12.00K
Jun 23, 2020
12.00K
Grant
Jun 22
Form 4
12.00K
Jun 21, 2019
12.00K
Grant
Jun 20
Form 4
6.00K
Jan 17, 2019
6.00K
Grant
Jan 15
Form 4
18.60K
Dec 11, 2018
18.60K
Grant
Dec 07
Form 3
Dec 11, 2018
Showing 5 results

TESARO, Inc.

President & COO
Updated Jan 22, 2019
Form 4
-100.00%
-1.83M
$75.00
-$44.28M
Jan 22, 2019
Disposition
Jan 22
Form 4
-3.46%
-11.57K
$39.86
-$691.19K
Dec 21, 2018
886.49K
Options
Dec 20
Form 4
230.87%
108.95K
$54.86
-$211.49K
Mar 05, 2018
719.71K
Sell-Options
ScheduledMar 01
Form 4
68.52%
27.41K
$177.61
-$697.47K
Mar 03, 2017
630.98K
Sell-Options
ScheduledMar 01 - Mar 02
Form 4
120.00K
Mar 03, 2016
120.00K
Grant
Mar 01
Form 4
115.00K
Mar 10, 2015
Grant
Mar 06
Form 4/A
105.00K
Mar 07, 2014
105.00K
Grant
Feb 27
Form 4
60.00%
105.00K
Mar 04, 2014
280.00K
Grant
Feb 27
Form 4
175.00K
Mar 08, 2013
175.00K
Grant
Mar 06
Form 4
-24.06%
-178.57K
Jul 06, 2012
563.57K
Options
Jul 03
Form 3
Jun 27, 2012
492.14K
Showing 11 results

ELI LILLY & Co

Investor
Updated Oct 22, 2024
Form 4
0.72%
11.00
$906.13
$9.97K
Oct 22, 2024
1.65K
Grant
Oct 21
Form 4
0.72%
11.00
$923.54
$10.16K
Sep 17, 2024
1.64K
Grant
Sep 16
Form 4
0.73%
11.00
$921.81
$10.14K
Aug 20, 2024
1.62K
Grant
Aug 19
Form 4
0.67%
10.00
$950.46
$9.50K
Jul 16, 2024
1.61K
Grant
Jul 15
Form 4
0.74%
11.00
$885.01
$9.74K
Jun 18, 2024
1.60K
Grant
Jun 17
Form 4
0.88%
13.00
$783.18
$10.18K
May 21, 2024
1.59K
Grant
May 20
Form 4
0.89%
13.00
$750.77
$9.76K
Apr 16, 2024
1.58K
Grant
Apr 15
Form 4
0.90%
13.00
$762.66
$9.91K
Mar 19, 2024
1.56K
Grant
Mar 18
Form 4
0.91%
13.00
$755.66
$9.82K
Feb 21, 2024
1.55K
Grant
Feb 20
Form 4
1.13%
16.00
$634.57
$10.15K
Jan 17, 2024
1.54K
Grant
Jan 16
Form 4
1.21%
17.00
$579.76
$9.86K
Dec 19, 2023
1.52K
Grant
Dec 18
Form 4
33.49%
352.00
$597.60
$210.36K
Nov 21, 2023
1.50K
Grant
Nov 20
Form 4
1.55%
16.00
$616.64
$9.87K
Oct 17, 2023
1.15K
Grant
Oct 16
Form 4
1.67%
17.00
$571.28
$9.71K
Sep 20, 2023
1.13K
Grant
Sep 18
Form 4
1.80%
18.00
$550.50
$9.91K
Aug 22, 2023
1.12K
Grant
Aug 21
Form 4
2.25%
22.00
$447.14
$9.84K
Jul 18, 2023
1.10K
Grant
Jul 17
Form 4
2.30%
22.00
$451.95
$9.94K
Jun 21, 2023
1.08K
Grant
Jun 20
Form 4
2.47%
23.00
$434.51
$9.99K
May 16, 2023
1.05K
Grant
May 15
Form 4
2.99%
27.00
$372.35
$10.05K
Apr 19, 2023
1.03K
Grant
Apr 17
Form 3/A
Apr 03, 2023
346.00
Form 4
4.80%
30.00
$333.60
$10.01K
Mar 22, 2023
655.00
Grant
Mar 20
Form 4
5.06%
30.00
$327.51
$9.83K
Feb 22, 2023
623.00
Grant
Feb 21
Form 4
4.96%
28.00
$357.74
$10.02K
Jan 19, 2023
593.00
Grant
Jan 17
Form 4
5.21%
28.00
$357.78
$10.02K
Dec 20, 2022
565.00
Grant
Dec 19
Form 4
202.82%
359.00
$361.17
$129.66K
Nov 22, 2022
536.00
Grant
Nov 21
Form 4
28.95%
33.00
$305.09
$10.07K
Sep 21, 2022
147.00
Grant
Sep 19
Form 4
39.02%
32.00
$313.94
$10.05K
Aug 16, 2022
114.00
Grant
Aug 15
Form 4
60.78%
31.00
$321.77
$9.97K
Jul 19, 2022
82.00
Grant
Jul 18
Form 4
183.33%
33.00
$297.34
$9.81K
Jun 22, 2022
51.00
Grant
Jun 21
Form 4
18.00
$299.38
$5.39K
May 18, 2022
18.00
Grant
May 16
Form 3
May 16, 2022
Showing 31 results

MGI PHARMA INC

Exec VP & Chief Scientific Off
Updated Jan 30, 2008
Form 4
-100.00%
-218.25K
$28.78
-$5.26M
Jan 30, 2008
Disposition
Jan 28
Form 4
-47.97%
-16.82K
$41.00
-$689.78K
Jan 25, 2008
18.25K
Disposition
Jan 23
Form 4
-4.56%
-1.59K
$23.57
-$37.41K
Sep 05, 2007
35.07K
Tax
Aug 31
Form 4
-0.79%
-278.00
$25.37
-$7.05K
Jul 16, 2007
36.66K
Tax
Jul 15
Form 4/A
-50.00%
-50.00K
$22.87
-$1.14M
Apr 19, 2007
86.94K
Grant
Feb 20
Form 3/A
Apr 19, 2007
15.58K
Form 4
-50.00%
-50.00K
$22.87
-$1.14M
Feb 22, 2007
75.44K
Grant
Feb 20
Form 4
-1.00%
-238.00
$17.21
-$4.10K
Oct 04, 2006
25.06K
Tax
Oct 03
Form 4
-9.08%
-2.38K
$15.06
-$35.86K
Sep 05, 2006
25.30K
Tax
Sep 03
Form 4
1,526.59%
95.00K
$15.13
$1.13M
Sep 01, 2006
102.68K
Grant
Aug 31
Form 4
-7.91%
-277.00
$20.58
-$5.70K
Jul 17, 2006
4.68K
Tax
Jul 15
Form 3/A
Jul 17, 2006
4.08K
Form 4
3.00K
Oct 06, 2005
3.58K
Grant
Oct 03
Form 3
Oct 06, 2005
584.00
Showing 14 results